ISU Abxis Financials

086890 Stock  KRW 4,660  140.00  2.92%   
We strongly advise to harness ISU Abxis fundamental analysis to see if markets are currently undervaluing or overvaluing the company. Simply put, you can make use of it to find out if ISU Abxis is indeed mispriced or if you can make any profits on it by purchasing it and then waiting for the market to recognize its mistake and reprise the security. We were able to analyze thirty-two available reported financial drivers for ISU Abxis, which can be compared to its competitors. The stock experiences an unexpected downward movement. The market is reacting to new fundamentals. Check odds of ISU Abxis to be traded at W4473.6 in 90 days.
  
Understanding current and past ISU Abxis Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of ISU Abxis' financial statements are interrelated, with each one affecting the others. For example, an increase in ISU Abxis' assets may result in an increase in income on the income statement.
Please note, the presentation of ISU Abxis' financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, ISU Abxis' management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of ISU Abxis' management manipulating its earnings.

ISU Abxis Stock Summary

ISU Abxis competes with Samsung Biologics, SK Bioscience, Green Cross, MedPacto, and Prestige Biologics. ISU Abxis Co., Ltd., a biopharmaceutical company, develops and markets products for the treatment of cancer and rare diseases worldwide. ISU Abxis Co., Ltd. is headquartered in Seongnam, South Korea. ISU ABXIS is traded on Korean Securities Dealers Automated Quotations in South Korea.
InstrumentKorea Stock View All
ExchangeKOSDAQ
ISINKR7086890001
Business AddressGlobal RD Center
SectorHealthcare
IndustryBiotechnology
BenchmarkDow Jones Industrial
Websitewww.abxis.com
Phone82 3 1696 4700
CurrencyKRW - South Korean Won
You should never invest in ISU Abxis without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of ISU Stock, because this is throwing your money away. Analyzing the key information contained in ISU Abxis' financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.

ISU Abxis Key Financial Ratios

ISU Abxis' financial ratios allow both analysts and investors to convert raw data from ISU Abxis' financial statements into concise, actionable information that can be used to evaluate the performance of ISU Abxis over time and compare it to other companies across industries.

ISU Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining ISU Abxis's current stock value. Our valuation model uses many indicators to compare ISU Abxis value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across ISU Abxis competition to find correlations between indicators driving ISU Abxis's intrinsic value. More Info.
ISU Abxis Co is rated third in return on equity category among its peers. It is rated fifth in return on asset category among its peers . Comparative valuation analysis is a catch-all model that can be used if you cannot value ISU Abxis by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for ISU Abxis' Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.

ISU Abxis Systematic Risk

ISU Abxis' systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. ISU Abxis volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
Incorrect Input. Please change your parameters or increase the time horizon required for running this function. The output start index for this execution was zero with a total number of output elements of zero. The Beta measures systematic risk based on how returns on ISU Abxis correlated with the market. If Beta is less than 0 ISU Abxis generally moves in the opposite direction as compared to the market. If ISU Abxis Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one ISU Abxis is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of ISU Abxis is generally in the same direction as the market. If Beta > 1 ISU Abxis moves generally in the same direction as, but more than the movement of the benchmark.

ISU Abxis December 19, 2024 Opportunity Range

Along with financial statement analysis, the daily predictive indicators of ISU Abxis help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of ISU Abxis Co. We use our internally-developed statistical techniques to arrive at the intrinsic value of ISU Abxis Co based on widely used predictive technical indicators. In general, we focus on analyzing ISU Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build ISU Abxis's daily price indicators and compare them against related drivers.

Complementary Tools for ISU Stock analysis

When running ISU Abxis' price analysis, check to measure ISU Abxis' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy ISU Abxis is operating at the current time. Most of ISU Abxis' value examination focuses on studying past and present price action to predict the probability of ISU Abxis' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move ISU Abxis' price. Additionally, you may evaluate how the addition of ISU Abxis to your portfolios can decrease your overall portfolio volatility.
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Equity Valuation
Check real value of public entities based on technical and fundamental data
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing